CEO: David M. Stack

Sector: Health Technology

Exchange: NASDAQ

Country: US

Description: Pacira Biosciences, Inc. develops and manufactures injectable therapeutic products. The firm engages in the development, commercialization and manufacture of pharmaceutical products for use in postsurgical outcomes for acute care practitioners and their patients. Its flagship product, EXPAREL, redefines pain management after surgery as an opioid-free alternative indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia. The company was founded in December 2006 and is headquartered in Parsippany, NJ.

Key numbers

Market Capitalization:2220608576
Shares Outstanding: 42120800
Float: 41575041
Next Earning Date:2020-10-28
TTm EPS: -0.0031
TTm Dividend Rate:
200 days moving average:43.41
50 days moving average: 49.23
One day percent Change: 0.71

2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,